Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.790 +0.390 (+5.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
64 65 Next >
Better Bull Market Buy: Novavax vs. Pfizer
Bull markets usually favor stocks with promising growth prospects. 
Via The Motley Fool
Get Rich Quick With These 3 Stocks to Buy Now
Although these market ideas are extremely speculative, their upcoming catalysts could make them stocks to buy now. 
Via InvestorPlace
Where Will Novavax Be in 10 Years?
Without any windfalls on the horizon, times are dire for this biotech. 
Via The Motley Fool
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly. 
Via InvestorPlace
3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market
Bull markets favor growth stocks so now could be the time for these players to shine. 
Via The Motley Fool
Better Recovery Story Buy: Novavax vs. Teladoc
Both stocks have fallen more than 90% from their peak. 
Via The Motley Fool
Could Novavax Stock Help You Become a Millionaire?
Novavax aims to win with its coronavirus/flu vaccine candidate, now in clinical trials. 
Via The Motley Fool
Looking Into Novavax's Recent Short Interest
 
Via Benzinga
Is It Too Late to Buy Novavax Stock?
The biotech could fade into irrelevance soon. 
Via The Motley Fool
Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option
Novavax's R21/Matrix-M malaria vaccine, with 75% efficacy in seasonal areas. Affordable at $3 per dose, it outshines GSK's vaccine. Global rollout expected mid-2024. 
Via Benzinga
Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts
The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market. 
Via InvestorPlace
Topics Workforce
3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts
If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year. 
Via The Motley Fool
1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell
This biotech isn't at the end of the road just yet, but don't bet on a revival. 
Via The Motley Fool
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
The stock is high risk, but rewards could be great if all works out well for Novavax. 
Via The Motley Fool
Where Will Novavax Be in 5 Years?
Can the beaten-down stock turn things around? 
Via The Motley Fool
What's Going On With Novavax Stock?
Novavax Inc (NASDAQ: NVAX) shares are volatile. 
Via Benzinga
Is Novavax Stock a Buy Now?
The company's shares may look cheap on the surface, but don't be too quick to jump in. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Novavax faces a couple of key issues that could be crucial for the stock price. 
Via The Motley Fool
5 Stocks With Short Interest Over 40%: Possible Short Squeeze Plays
Short selling can be profitable, but sometimes when the stock moves against short sellers and begins to rise, the short sellers jump in to buy shares to cover their positions, creating what is called a... 
Via Talk Markets
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value. 
Via InvestorPlace
Time to Buy These 3 Stocks That Just Hit a 52-Week Low?
Sometimes buying stocks at a 52-week low is a chance to buy a good company at great prices but you need to see if the business is busted. 
Via InvestorPlace
3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts
High-water price targets from select analysts imply triple-digit gains in the new year for three former highfliers. 
Via The Motley Fool
7 Magnificent Stocks That Can Double Your Money in 2024
Triple-digit returns could be just a click of the buy button away. 
Via The Motley Fool
Smart Shorts: 7 Meme Stocks to Bet Against in 2024
These seven meme stocks have surged as speculators declare "the coast is clear," but a big reversal for each of them may be forthcoming. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
3 Heavily Shorted Stocks That Still Won’t See a Squeeze
These are the heavily shorted stocks to avoid as they are likely to continue trending lower on the back of very weak fundamentals. 
Via InvestorPlace
3 Meme Stocks That Could Fade Away in 2024
These are the meme stocks to avoid or sell as they have extremely weak fundamentals and are unlikely to recover from a financial perspective. 
Via InvestorPlace
What's Going On With Novavax Hitting A New 52-Week Low?
Novavax Inc (NASDAQ: NVAX) shares are trading lower by 4.4% to $5.08 Wednesday afternoon. 
Via Benzinga
This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Camtek Ltd. 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback